Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Hydromorphone Hydrochloride Injection

Approval Number

国药准字H20217021

Company宜昌人福药业有限责任公司

Registration Date

August 15, 2022

Previous Approval Numbers

国药准字H20217021

Drug Information

Generic Name

盐酸氢吗啡酮注射液

Trade Name

锐宁

Dosage Form

注射剂

Strength

1ml:2mg

Drug Type

化学药品

Registration Date

August 15, 2022

Company Information

Applicant Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌开发区大连路19号

Manufacturing Company

Company Name宜昌人福药业有限责任公司

Company Address

1.湖北省宜昌开发区大连路19号,2.湖北省宜昌市东临路517号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸氢吗啡酮注射液 - NMPA 批准文号 | MedPath